Essential Disease Biology Data for Successful Drug Development
The research to understanding disease biology and identify promising targets is a difficult and expensive process whose accuracy can determine downstream success – or failures. Making the best early drug discovery and development decisions can mitigate later-stage – and more expensive – failures in the clinic.
Elsevier R&D Solutions’ technology provides critical biological data and enables collaboration so early drug development is as successful as possible – enabling drug companies to focus only on the targets that are most likely to succeed.
Elsevier R&D Solutions for Pharma & Life Sciences
Pathway Studio facilitates the interpretation of experimental data, giving greater insight into the mechanisms of disease and accelerating biological research.
Elsevier R&D Solutions Professional Services team helps drive pharmaceutical research in innovative directions by resolving challenges with data quality and integration, resulting in data that is easier to compare, analyze, interpret and share.
Elsevier’s customized Text Mining service provides meaningful answers to complex questions through the retrieval of highly specified information from unstructured content.
ScienceDirect, Elsevier’s leading information solution for both industry and university researchers, enables researchers to more effectively and efficiently search authoritative, full-text scientific, technical and health content through the use of smart, intuitive functionality.
Scopus helps researchers detect trends, find research partnerships and identify key opinion leaders with the world’s largest abstract and citation database of peer-reviewed literature, complete with tools to track, analyze and visualize scholarly research coming out of both industry and universities.
Real Stories. Real Science. Real Time.
Visit the Hive to explore how biotech and pharma start-ups are using Elsevier R&D solutions to solve for early-stage drug discovery and development. Watch videos, read real-world case studies and learn how early innovation starts with rapid results and early access to research that is crucial to reducing the likelihood of costly late stage failures and mitigating risk.
Reducing the Likelihood of Late-Stage Failures
Investments in pre-clinical disease biology research can improve your chances for downstream success.
The Impact of Modern Disease Biology Solutions
on Pharmaceutical Development
A deeper understanding of disease biology is facilitated by modern research solutions, such as text-mining tools and modeling software.
Understanding Diseases: Deciphering Complex Biological Processes
Understanding complex biological processes is critical to finding the next life-changing drug.
From Big Data to Drug Targets: Harnessing the Power of Literature
Can modern text-mining solutions handle full-text literature reliably so that all the relevant information is available to inform decisions in pharmaceutical R&D?
The Power of Mining Full-Text Articles for Pathway Analysis
Not all important scientific facts are found in article abstracts. Discover how Elsevier’s solution for disease biology can help you find what you’re missing.
Download the white paper (PDF, 664kb)